CLINICAL TRIALS PROFILE FOR ETHRANE

All Clinical Trials for ETHRANE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00815269 ↗	Vasodilation Effect of Inhalational Anesthetics	Completed	Nanjing Medical University	N/A	2008-12-01	Previous studies on animals suggest that inhalational anesthetics can reduce vascular tension in vitro resulting in vasodilation and decrease in blood pressure. This role for inhalational anesthetics has essential clinical implications such as the condition of sepsis or septic shock or other shock-associated states during which the blood vessel constricts strongly and leads to circulation dysfunction. The vasodilation property of these anesthetics including halothane, isoflurane, sevoflurane, desflurane and enflurane enables them to be better options than other general anesthetics in many clinical conditions needing the vasculature to be dilated. The investigators hypothesized that these inhalational anesthetics can evoke vasodilation measured with ultrasonography during general anesthesia in vivo as the in vitro studies displayed.

Clinical Trial Conditions for ETHRANE

Condition Name

Condition Name for ETHRANE
Intervention	Trials
General Anesthesia	1

Condition MeSH

Condition MeSH for ETHRANE
Intervention	Trials

Clinical Trial Locations for ETHRANE

Trials by Country

Trials by Country for ETHRANE
Location	Trials
China	1

Clinical Trial Progress for ETHRANE

Clinical Trial Phase

Clinical Trial Phase for ETHRANE
Clinical Trial Phase	Trials
N/A	1

Clinical Trial Status

Clinical Trial Status for ETHRANE
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for ETHRANE

Sponsor Name

Sponsor Name for ETHRANE
Sponsor	Trials
Nanjing Medical University	1

Sponsor Type

Sponsor Type for ETHRANE
Sponsor	Trials
Other	1